Recent Progress in the Development of Novel Mycobacterium Cell Wall Inhibitor to Combat Drug-Resistant Tuberculosis

Despite decades of research in drug development against TB, it is still the leading cause of death due to infectious diseases. The long treatment duration, patient noncompliance coupled with the ability of the tuberculosis bacilli to resist the current drugs increases multidrug-resistant tuberculosi...

Descripción completa

Detalles Bibliográficos
Autor principal: Belete, Tafere Mulaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131376/
https://www.ncbi.nlm.nih.gov/pubmed/35645569
http://dx.doi.org/10.1177/11786361221099878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131376/
https://www.ncbi.nlm.nih.gov/pubmed/35645569
http://dx.doi.org/10.1177/11786361221099878

Ejemplares similares